New drug AV-001 aims to help hospitalized pneumonia patients breathe easier
Disease control
Recruiting now
This study tests an experimental drug called AV-001 in 120 hospitalized adults with pneumonia who need extra oxygen. The drug is given daily through an IV and compared to a placebo, alongside standard care. The goal is to see if AV-001 is safe and helps patients recover faster fr…
Phase: PHASE2 • Sponsor: Vasomune Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:00 UTC